US$ 23.67
glp-1 medications market 2025 Agonists Weight Loss Drugs Report, 2025-2030 GLP-1 Supplement Market Size, Share,
Description
Whilst gastrointestinal side effects such as nausea and diarrhoea are well-recognised, some patients report joint pain during treatment

Diabetes and anxiety in US adults: findings from the 2006 behavioral risk factor surveillance system

p = 0.120

The pipeline is staggering, with new GLP 3s, Retatrutide, CagriSema, and MariTide each promising to quiet the noise even further

Samet Yardmc

Drug Safety